Monitoring of Low-Risk Hypertension Patients

Identifying Attributes

Care Settings
Primary Care
Country
Estonia
Publishing Organisation
Family Physicians Quality System Indicators
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Domain
Other Clinical

Defining Attributes

Definition

The percentage of low-risk hypertension patients with; (1) determined glucose or glycated haemoglobin (HbA1c), (2) counselling of the family nurse performed once a year in the reviewed year, (3) total serum cholesterol in the blood serum determined for at least 1 x 3 years.

Numerator

The number of low-risk hypertension patients who have glucose and total cholesterol in the blood serum determined and a family nurse's consultation performed.

Denominator

All patients with a diagnosis of I10-I15 (ODC -10 codes) and marked with Grade 1 in the list of patients with chronical illnesses forwarded by the Health Insurance Fund in the current (reviewed) year and approved by the family physician.

Exclusions

The following cases are excluded; if according to the population register, the person has left Estonia (lives abroad) or the corresponding diagnosis of chronic illness is on the treatment invoice only with the extension "0 - diagnosis unspecified".

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Collection and Reporting Attributes

Type of Data Collection
Standardised clinical data
Data Collection Methods

Estonian Health Insurance Fund database

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Merilind et al. Pay for performance of Estonian family doctors and impact of different practice- and patient-related characteristics on a good outcome: A quantitative assessment

Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
04 November 2025